Reports
Sale
Global Surrogacy Market Size, Share, Trends, Growth, Report: By Type: Gestational Surrogacy, Traditional Surrogacy; By Technology: IVF with ICSI, IVF without ICSI, Intrauterine Insemination, Others; By End User: Hospitals, IVF Centres, Others; Regional Analysis; Patent Analysis; Grants Analysis; Funding Analysis; Supplier Landscape; 2024-2032
Global Surrogacy Market Outlook
The global surrogacy market size was valued at USD 81.5 billion in 2023, driven by the increasing infertility rates and advancements in medical technology across the globe. The market size is anticipated to grow at a CAGR of 24.3% during the forecast period of 2024-2032 to achieve a value of USD 577.8 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Surrogacy Market Overview
Surrogacy is a type of assisted reproduction in which the intended parents collaborate with a surrogate mother who bears the baby until it is born. Traditional and gestational surrogacy are the two forms of assisted reproductive techniques utilised in surrogacy. Traditional method includes using a surrogate's eggs to make the baby's biological mother while in gestational, the surrogate has no biological or genetic connection to the child.
Due to the increasing adoption of gestational methods by surrogacy experts and the growing technological developments, the demand for gestational surrogacy around the world is significantly high and is expected to continue during the forecast period. Additionally, the emotional challenges of conventional surrogacy are driving the adoption of gestational surrogacy. Due to the high preference for gestational surgery due to fewer legal problems, this category is projected to account for a significant market share in the forecast period.
The market is further expected to be driven by the increasing awareness and supporting behaviour of legal bodies of the government exemplified by the decisions made by them in the court. For example, in early 2023, a male couple was allowed by the District Court of The Hague to have parental rights over children born from a surrogacy trajectory in the United States. The district court ruled that the decision would be recognized in the Netherlands too. Such approvals and decisions by the legal courts are expected to drive market growth as most of the LGBTQ+ community members will also collectively benefit from them in several regions across the world.
The market growth is significantly driven by the increase in the number of cases of infertility issues among people. For example, low sperm count or problems with egg or sperm production. Hormonal fluctuations, stress, alcohol use, and steroid use, all contribute to an increase in infertility instances. Furthermore, technical developments in assisted reproductive technologies as well as increased awareness of infertility treatments such as sperm/egg donation and in-vitro fertilisation are likely to fuel the global surrogacy market growth in the forecast period.
Furthermore, the high availability of fertility clinics in the market is further pushing the market growth. The rise in the prevalence of polycystic ovarian syndrome in women leads to difficulty in conceiving a child, resulting in escalated demand for surrogate mothers which is a major factor expected to contribute to the market growth. The increasing awareness related to the rights of same-sex weddings is expected to provide attractive development possibilities to the market. Furthermore, the surge in fertility tourism is projected to give sufficient chances for growth, particularly in emerging nations.
Rising Prevalence of Infertility
The growth of the market is primarily driven by the rising prevalence of infertility and other reproductive issues across the world. Infertility affects millions of people every year, one in every six people of reproductive age, which is nearly 17.5% of the total adult population, is affected by infertility in their life. Assisted reproductive technologies have been in the market for over three decades and have intervened in the birth of more than 5 million children across the world. These technologies are still widely inaccessible because of the price point, which is unaffordable for the majority of the population, especially in low-income countries.
Rise in Research Studies
In October 2023, new research from Shady Grove Fertility (SGF), a US Fertility practice, concluded that fertility patients who have undergone a saline-infused sonogram (SIS) can proceed with intrauterine insemination (IUI) in the same cycle and expect comparable pregnancy rates as if they had waited for another cycle.
Such studies enable patients to move forward with fertility treatment more quickly in their IUI cycles as fertility treatments are usually very time-consuming. This may support the increasing demand for IUI among people, further bolstering the global surrogacy market growth.
Innovative Approaches Poised to Transform the Market Trajectory
In April 2023, a group of engineers created an automated IVF device. With an extremely crazy experiment, these engineers were able to successfully fertilize more than a dozen eggs. They also claimed that the first humans (two baby girls) had already been born after fertilization by a robot.
The startup company that developed the robot, Overture Life, emphasized how their device is an initial step toward automating in vitro fertilization, or IVF, and potentially making the procedure less expensive and far more common. With IVF labs staffed by trained embryologists performing the entire procedure could be replaced by this robotic procedure, nearly automating the whole process, and boosting the global surrogacy market demand. This innovation may also gain traction among investors to hold a rigid position in the market. Furthermore, Overture has filed a patent application describing a “biochip” for an IVF lab in miniature, complete with hidden reservoirs containing growth fluids, and tiny channels for sperm to wiggle through.
By applying for the patent, the company has shown how determined they are to experiment and innovate the domain of IVF and other procedures that may enable people with infertility issues to have babies and have a family.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Surrogacy Market Segmentations
Market Breakup by Type
- Gestational Surrogacy
- Traditional Surrogacy
Market Breakup by Technology
- IVF with ICSI
- IVF without ICSI
- Intrauterine Insemination
- Others
Market Breakup by End User
- Hospitals
- IVF Centres
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Surrogacy Market Regional Analysis
Asia Pacific is expected to occupy a significant share of the market in the forecast period because surrogacy in developing nations like India is less expensive than in affluent countries like the United States and Canada, adding to this region's market growth. Furthermore, in the forecast period, the best technical outreach and inclination for surrogacy, particularly IVF kinds, is expected to further help in the surrogacy market growth.
In addition, due to the rising number of specialised clinics for assisted reproductive technologies, the surrogacy market in this area is expected to witness healthy growth. Hence, the region is expected to provide lucrative opportunities to the key players operating in the surrogacy market.
In June 2023, Beijing's government announced that it would cover 16 types of assisted reproduction technology under the city's health care system from July 1, the latest move by authorities to boost China's flagging birth rate. In-vitro fertilization, embryo transplantation, freezing, and storing semen are some of the treatments that would be included under basic insurance, said Du Xin, deputy director of Beijing's Municipal Medical Insurance Bureau.
This move was taken as China is facing a decline in birth rates. The number of newborns dropped to a record low of 6.77 per 1,000 people last year and is expected to decline further in 2023. Such initiatives may enable people to consider using procedures like IVF, IUI, and others to find a solution for their personal choices and infertility issues boosting the surrogacy market growth.
The initiative to cover 16 types of ART may increase access among people, the financial support is expected to boost the demand for such procedures including surrogacy, among people, propelling the market growth.
Global Surrogacy Market: Competitor Landscape
In April 2023, US Fertility ("USF"), a nationwide fertility-focused physician practice management platform providing non-clinical and administrative services to physician-owned fertility practices, and Ovation Fertility ("Ovation"), a leading national network of reproductive endocrinologists and scientific thought leaders, announced a definitive agreement to combine operations. This collaboration will drive growth and innovation while leveraging best practices to improve patient access, experience, and outcomes.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- New Hope Fertility Clinic
- Houston Fertility Center
- Ovation Fertility
- Extraordinary Conceptions
- CARE Fertility
- Growing Generations, LLC
- IVI RMA GLOBAL
- CLINIC SCANFERT
- BOURN HALL FERTILITY CLINIC
- NOVA IVI FERTILITY
- Associates Reproductive Medicine & Infertility
- Cardone
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Technology |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Surrogacy Market (2017-2032) Overview
3.1 Global Surrogacy Market Historical Value (2017-2023)
3.2 Global Surrogacy Market Forecast Value (2024-2032)
4 Global Surrogacy Market (2017-2032) Landscape*
4.1 Global Surrogacy Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Surrogacy Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
5 Global Surrogacy Market (2017-2032) Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Surrogacy Market (2017-2032) Segmentation
6.1 Global Surrogacy Market (2017-2032) by Type
6.1.1 Market Overview
6.1.2 Gestational Surrogacy
6.1.3 Traditional Surrogacy
6.2 Global Surrogacy Market (2017-2032) by Technology
6.2.1 Market Overview
6.2.2 IVF with ICSI
6.2.3 IVF without ICSI
6.2.4 Intrauterine Insemination
6.2.5 Others
6.3 Global Surrogacy Market (2017-2032) by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 IVF Centres
6.3.4 Others
6.4 Global Surrogacy Market (2017-2032) by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Surrogacy Market (2017-2032)
7.1 North America Surrogacy Market (2017-2032) by Type
7.1.1 Market Overview
7.1.2 Gestational Surrogacy
7.1.3 Traditional Surrogacy
7.2 North America Surrogacy Market (2017-2032) by Technology
7.2.1 Market Overview
7.2.2 IVF with ICSI
7.2.3 IVF without ICSI
7.2.4 Intrauterine Insemination
7.2.5 Others
7.3 North America Surrogacy Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Surrogacy Market (2017-2032)
8.1 Europe Surrogacy Market (2017-2032) by Type
8.1.1 Market Overview
8.1.2 Gestational Surrogacy
8.1.3 Traditional Surrogacy
8.2 Europe Surrogacy Market (2017-2032) by Technology
8.2.1 Market Overview
8.2.2 IVF with ICSI
8.2.3 IVF without ICSI
8.2.4 Intrauterine Insemination
8.2.5 Others
8.3 Europe Surrogacy Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Surrogacy Market (2017-2032)
9.1 Asia Pacific Surrogacy Market (2017-2032) by Type
9.1.1 Market Overview
9.1.2 Gestational Surrogacy
9.1.3 Traditional Surrogacy
9.2 Asia Pacific Surrogacy Market (2017-2032) by Technology
9.2.1 Market Overview
9.2.2 IVF with ICSI
9.2.3 IVF without ICSI
9.2.4 Intrauterine Insemination
9.2.5 Others
9.3 Asia Pacific Surrogacy Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 ASEAN
9.3.6 Others
10 Latin America Surrogacy Market (2017-2032)
10.1 Latin America Surrogacy Market (2017-2032) by Type
10.1.1 Market Overview
10.1.2 Gestational Surrogacy
10.1.3 Traditional Surrogacy
10.2 Latin America Surrogacy Market (2017-2032) by Technology
10.2.1 Market Overview
10.2.2 Gestational Surrogacy
10.2.3 Traditional Surrogacy
10.3 Latin America Surrogacy Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Surrogacy Market (2017-2032)
11.1 Middle East and Africa Surrogacy Market (2017-2032) by Type
11.1.1 Market Overview
11.1.2 Gestational Surrogacy
11.1.3 Traditional Surrogacy
11.2 Middle East and Africa Surrogacy Market (2017-2032) by Technology
11.2.1 Market Overview
11.2.2 IVF with ICSI
11.2.3 IVF without ICSI
11.2.4 Intrauterine Insemination
11.2.5 Others
11.3 Middle East and Africa Surrogacy Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 New Hope Fertility Clinic
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Houston Fertility Center
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Ovation Fertility
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Extraordinary Conceptions
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 CARE Fertility
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Growing Generations, LLC
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 IVI RMA GLOBAL
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 CLINIC SCANFERT
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 BOURN HALL FERTILITY CLINIC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 NOVA IVI FERTILITY
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Associates Reproductive Medicine & Infertility
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Cardone
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Surrogacy Market (2017-2032) Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 81.5 billion in 2023, driven by rising infertility problems among people.
The market is anticipated to grow at a CAGR of 24.3% during the forecast period of 2024-2032 and is likely to reach a market value of USD 577.8 billion by 2032.
The market growth is driven by factors such as rising technological advancements in fertility procedures, increasing rates of gamete donations, rising disposable income specifically in developed countries, rising awareness of infertility treatments, and the rise in the prevalence of polycystic ovarian syndrome, companies innovating to bring new technologies into the surrogacy market and increasing collaboration between market players.
Government initiatives such as the Beijing government announcing the inclusion of 16 types of ART technologies under the healthcare system, are among major trends influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Types of surrogacies include gestational surrogacy and traditional surrogacy.
Surrogacy may involve IVF with ICSI, IVF without ICSI, and intrauterine insemination, among others.
End users in the market are hospitals and IVF centres, among others.
Key players involved in the market are New Hope Fertility Clinic, Houston Fertility Center, Ovation Fertility, Extraordinary Conceptions, CARE Fertility, Growing Generations, LLC, IVI RMA GLOBAL, CLINIC SCANFERT, BOURN HALL FERTILITY CLINIC, NOVA IVI FERTILITY, Associates Reproductive Medicine & Infertility, and Cardone.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER